Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Open Source Software
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Drug targeting of oncogenic pathways in melanoma.
Microphthalmia-Associated Transcription Factor
A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.
The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFa.
MITF Modulates Therapeutic Resistance through EGFR Signaling.
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance.
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.
A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanoma.
Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFN? pathways.
Microphthalmia Associated Transcription Factor